Articles Archives - Page 343 of 750

MondayJan 10, 2022 10:14 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO Participation in Upcoming Events Recognizes Company Expertise

CEO to participate in panel discussion, fireside chat focusing on psychedelics The company is engineering next-generation psychedelic molecules as it works to transform the mental health treatment landscape CYBN is implementing a three-pillar strategy Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing psychedelics to therapeutics, is gaining recognition as a leader in the psychedelic space. Evidence of this can be seen in the Cybin CEO’s upcoming participation in two virtual investor conferences (https://ibn.fm/1zAF4). The company announced that CEO Doug Drysdale has been invited to participate in a panel discussion titled "Psychedelics: More Than Just a Trip" during…

MondayJan 10, 2022 9:53 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Independent Review Board Approval for Its Most Ambitious, Comprehensive Human Study Yet

Lexaria has received approval from the Independent Review Board for its DehydraTECH-CBD Human Clinical HYPER-H21-4 study The approval signals the company has taken the appropriate steps to protect the rights and welfare of human subjects participating in its fourth human study HYPER-H21-4 should "de-risk" outcomes prior to Lexaria's planned entry into regulatory pathways for the use of DehydraTECH-CBD to treat hypertension and perhaps other forms of cardiovascular disease Previous studies – HYPER-H21-1 and HYPER-H21-2 – have evidenced a remarkable, rapid, and safe drop in blood pressure with DehydraTECH-CBD A little less than two months after Lexaria Bioscience (NASDAQ: LEXX) announced…

FridayJan 07, 2022 9:30 am

Flora Growth Corp. (NASDAQ: FLGC), a 2021 Year Review

2021 marked the year when Flora Growth held its IPO - the company’s common shares commenced trading on the Nasdaq Capital Market in May under the ticker symbol “FLGC" It also marked the year when the company ventured into the European market, as well as other key regions such as Mexico Significant acquisitions for the 2021 calendar year included Koch & Gsell, Vessel Brand Inc., and GMP-Certified Laboratory Flora Growth also made notable appointments to its executive leadership as well as its board of directors Flora Growth (NASDAQ: FLGC) had an impressive year in 2021, highlighted by the company’s Initial…

FridayJan 07, 2022 9:30 am

GreenBox POS (NASDAQ: GBOX) Is ‘One to Watch’

GreenBox POS reported $8 million in revenue for Q3 2021 on $540 million processed transaction volume GreenBox’s guidance for FY2022 forecasts processing volume of at least $4.9 billion The company’s planned spinoff of its coyni smart contract token technology is expected to accelerate revenue growth GreenBox shareholders will have an opportunity to benefit from dividends in the coyni spin off IPO The company’s Board of Directors recently approved a share buy-back program GreenBox POS (NASDAQ: GBOX) is an emerging financial technology company leveraging proprietary security and token technology to build customized payment solutions for business. The company’s mission is to build…

FridayJan 07, 2022 9:00 am

Mullen Automotive Inc. (NASDAQ: MULN) Receives Rave Reviews Following Debut at LA Auto Show; Mullen FIVE RS Aims to Be World’s Fastest EV

Mullen Automotive launched the Mullen FIVE EV Crossover at the recent LA Auto Show, with the vehicle winning the auto show’s ZEVA(R) award for top all-electric SUV The Mullen FIVE has seen a spike in popularity following its debut, with the carmaker recently opting to lift the initial reservation limit to 25,000 vehicles The future Mullen FIVE’s RS is being modeled to usurp Tesla Model S Plaid’s title as the world’s fastest EV, with the ability to accelerate from 0-62 mph in a mere 1.9 seconds Mullen Automotive has recently entered a partnership with Germany's ARRK to support the engineering…

FridayJan 07, 2022 9:00 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA) Signs LOI with Maya to Co-Develop a Prescription Digital Therapeutics Platform Targeting a Trifecta Approach to Patient Care

Mydecine has signed a letter of intent with Maya detailing a collaborative partnership to develop a novel digital therapeutics (“DTx”) platform The DTx platform is expected to create a three-pronged approach to patient care by combining Mydecine’s Mindleap digital health platform with its medication-based treatments According to COO Damon Michaels, the new platform will provide improved adherence to treatment protocols, patient experience, biometric insights, and post-approval insurance reimbursements Both companies intend to pursue rigorous studies to achieve FDA clearance Regarded as the convergence of health care and software that has resulted in a new crop of life sciences technology helping…

FridayJan 07, 2022 9:00 am

Sugarmade Inc. (SGMD) Subsidiary Obtains Permit, Takes Key Step Toward Commercialization

SGMD’s Lemon Glow receives conditional use permit number from county Sugarmade’s seed-to-door vision separates the company from other players in the California cannabis marketplace Estimated for Lemon Glow property could reach as much as 64 tons of dry trimmed cannabis flower annually Sugarmade (OTC: SGMD) is making significant progress toward its end goal of becoming a central play in the growing California cannabis space. The company announced that its wholly owned subsidiary, Lemon Glow Company, has received a conditional use permit (“UP”) number from the Community Development Department of the County of Lake, California (https://ibn.fm/zkjLq). The permit, noted Sugarmade, is…

ThursdayJan 06, 2022 9:30 am

Cannabis Strategic Ventures Inc. (NUGS) Strengthens Foothold as Mounting Numbers Support Cannabis Legalization

An estimated 91% of U.S. adults (91%) say either that marijuana should be legal for medical and recreational use or that it should be legal for medical use only While cannabis remains an illegal substance federally, a growing number of states have legalized the substance An emerging leader in the U.S. cannabis marketplace, NUGS’ vision is to acquire, scale assets in the legal cannabis market A vast majority of adults in the United States say that marijuana should be legal for either medical and recreational use or at least for medical use, according to a recent Pew Research Center report (https://ibn.fm/zqnb9). Companies such as…

ThursdayJan 06, 2022 9:30 am

InnerScope Hearing Technologies Inc. (INND) Completes Key Acquisitions as Hearing Aid Market Poised for DTC Transition in 2022

The World Health Organization estimates by 2050 nearly 2.5 billion people will have some degree of hearing loss and at least 700 million will require hearing rehabilitation InnerScope Hearing Technologies has made transformational moves in 2021 to position itself as a leader in direct-to-consumer (“DTC”) sales of hearing aids and related products InnerScope recently acquired Hearing Assist II, Walmart’s largest hearing aid provider, and iHEAR Medical, the maker of the only FDA-cleared home hearing screener, setting up for what expects to be a record Q4 2021 As our homes have become our offices, schools, restaurants, and more throughout the coronavirus…

ThursdayJan 06, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Key Meeting with UK Regulatory Agency

Meeting takes company a step closer to advancing its lead investigational candidate CYB003 into clinical development CYB003 is designed for the treatment of two significant conditions: major depressive disorder (“MDD”) and alcohol use disorder (“AUD”) CEO notes that CYB003 has the potential to achieve better patient outcomes The coming year holds significant promise for Cybin (NEO: CYBN) (NYSE American: CYBN) for numerous reasons. The biopharmaceutical company has seen significant success in the execution of its strategic focus on progressing psychedelics to therapeutics, including its recent announcement that company representatives will hold a scientific advice meeting with the UK Medical and Healthcare…

Site Search

Company Search

Category: Articles

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO Participation in Upcoming Events Recognizes Company Expertise

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Independent Review Board Approval for Its Most Ambitious, Comprehensive Human Study Yet

Flora Growth Corp. (NASDAQ: FLGC), a 2021 Year Review

GreenBox POS (NASDAQ: GBOX) Is ‘One to Watch’

Mullen Automotive Inc. (NASDAQ: MULN) Receives Rave Reviews Following Debut at LA Auto Show; Mullen FIVE RS Aims to Be World’s Fastest EV

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: ONFA) Signs LOI with Maya to Co-Develop a Prescription Digital Therapeutics Platform Targeting a Trifecta Approach to Patient Care

Sugarmade Inc. (SGMD) Subsidiary Obtains Permit, Takes Key Step Toward Commercialization

Cannabis Strategic Ventures Inc. (NUGS) Strengthens Foothold as Mounting Numbers Support Cannabis Legalization

InnerScope Hearing Technologies Inc. (INND) Completes Key Acquisitions as Hearing Aid Market Poised for DTC Transition in 2022

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Key Meeting with UK Regulatory Agency

Market Basics

Newsletter Publishers

Public Companies